Annual Retained Earnings
-$304.56 M
-$26.48 M-9.52%
December 1, 2022
Summary
- As of February 10, 2025, DMK annual retained earnings is -$304.56 million, with the most recent change of -$26.48 million (-9.52%) on December 1, 2022.
- During the last 3 years, DMK annual retained earnings has fallen by -$124.04 million (-68.71%).
Performance
DMK Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Retained Earnings
-$323.47 M
-$1.39 M-0.43%
September 1, 2023
Summary
- As of February 10, 2025, DMK quarterly retained earnings is -$323.47 million, with the most recent change of -$1.39 million (-0.43%) on September 1, 2023.
- Over the past year, DMK quarterly retained earnings has dropped by -$22.23 million (-7.38%).
Performance
DMK Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
DMK Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -9.5% | -7.4% |
3 y3 years | -68.7% | -53.1% |
5 y5 years | -167.2% | -130.7% |
DMK Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | +9.5% | at low | +16.3% | at low |
5 y | 5-year | +68.7% | at low | +79.2% | at low |
alltime | all time | +2885.9% | at low | +3750.8% | at low |
DMK Pharmaceuticals Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sep 2023 | - | -$323.47 M(+0.4%) |
Jun 2023 | - | -$322.08 M(+2.7%) |
Mar 2023 | - | -$313.51 M(+2.9%) |
Dec 2022 | -$304.56 M(+9.5%) | -$304.56 M(+1.1%) |
Sep 2022 | - | -$301.24 M(+1.5%) |
Jun 2022 | - | -$296.84 M(+2.9%) |
Mar 2022 | - | -$288.44 M(+3.7%) |
Dec 2021 | -$278.09 M(+21.0%) | -$278.09 M(+3.3%) |
Sep 2021 | - | -$269.31 M(+4.8%) |
Jun 2021 | - | -$256.95 M(+3.8%) |
Mar 2021 | - | -$247.64 M(+7.7%) |
Dec 2020 | -$229.91 M(+27.4%) | -$229.91 M(+8.8%) |
Sep 2020 | - | -$211.34 M(+3.7%) |
Jun 2020 | - | -$203.85 M(+5.8%) |
Mar 2020 | - | -$192.59 M(+6.7%) |
Dec 2019 | -$180.52 M(+18.0%) | -$180.52 M(+2.2%) |
Sep 2019 | - | -$176.63 M(+4.1%) |
Jun 2019 | - | -$169.63 M(+4.8%) |
Mar 2019 | - | -$161.90 M(+5.8%) |
Dec 2018 | -$153.00 M(+34.2%) | -$153.00 M(+9.1%) |
Sep 2018 | - | -$140.19 M(+6.8%) |
Jun 2018 | - | -$131.32 M(+8.0%) |
Mar 2018 | - | -$121.62 M(+6.7%) |
Dec 2017 | -$114.00 M(+28.9%) | -$114.00 M(+7.6%) |
Sep 2017 | - | -$105.97 M(+6.8%) |
Jun 2017 | - | -$99.20 M(+5.3%) |
Mar 2017 | - | -$94.23 M(+6.5%) |
Dec 2016 | -$88.46 M(+28.2%) | -$88.46 M(+0.8%) |
Sep 2016 | - | -$87.79 M(+8.2%) |
Jun 2016 | - | -$81.14 M(+7.6%) |
Mar 2016 | - | -$75.43 M(+9.3%) |
Dec 2015 | -$69.02 M(+24.5%) | -$69.02 M(+5.6%) |
Sep 2015 | - | -$65.38 M(+5.1%) |
Jun 2015 | - | -$62.24 M(+6.2%) |
Mar 2015 | - | -$58.59 M(+14.6%) |
Dec 2014 | -$55.45 M(+20.2%) | - |
Sep 2014 | - | -$51.14 M(+4.3%) |
Jun 2014 | - | -$49.01 M(+6.2%) |
Mar 2014 | -$46.13 M(+21.5%) | -$46.13 M(+3.5%) |
Dec 2013 | - | -$44.58 M(+14.2%) |
Sep 2013 | - | -$39.05 M(+0.1%) |
Jun 2013 | - | -$39.02 M(+2.7%) |
Mar 2013 | -$37.98 M(+23.4%) | -$37.98 M(+4.5%) |
Dec 2012 | - | -$36.34 M(+5.7%) |
Sep 2012 | - | -$34.37 M(+2.6%) |
Jun 2012 | - | -$33.51 M(+8.9%) |
Mar 2012 | -$30.78 M(+19.0%) | -$30.78 M(+4.1%) |
Dec 2011 | - | -$29.58 M(+3.5%) |
Sep 2011 | - | -$28.59 M(+5.5%) |
Jun 2011 | - | -$27.11 M(+4.8%) |
Mar 2011 | -$25.87 M(+37.0%) | -$25.87 M(+4.7%) |
Dec 2010 | - | -$24.72 M(+14.3%) |
Sep 2010 | - | -$21.62 M(+7.1%) |
Jun 2010 | - | -$20.20 M(+6.9%) |
Mar 2010 | -$18.89 M | -$18.89 M(+31.5%) |
Dec 2009 | - | -$14.36 M(+7.1%) |
Sep 2009 | - | -$13.41 M(+4.2%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2009 | - | -$12.87 M(-89.8%) |
Mar 2009 | - | -$126.41 M(+0.2%) |
Dec 2008 | -$126.10 M(+1.2%) | -$126.10 M(+0.3%) |
Sep 2008 | - | -$125.78 M(+0.3%) |
Jun 2008 | - | -$125.45 M(+0.3%) |
Mar 2008 | - | -$125.06 M(+0.4%) |
Dec 2007 | -$124.57 M(+1.6%) | -$124.57 M(+0.5%) |
Sep 2007 | - | -$123.96 M(+0.3%) |
Jun 2007 | - | -$123.64 M(+0.4%) |
Mar 2007 | - | -$123.18 M(+0.4%) |
Dec 2006 | -$122.64 M(-7.3%) | -$122.64 M(-10.9%) |
Sep 2006 | - | -$137.61 M(+1.2%) |
Jun 2006 | - | -$135.97 M(+1.0%) |
Mar 2006 | - | -$134.66 M(+1.8%) |
Dec 2005 | -$132.31 M(+3.9%) | -$132.31 M(+1.5%) |
Sep 2005 | - | -$130.35 M(+2.2%) |
Jun 2005 | - | -$127.55 M(-3.7%) |
Mar 2005 | - | -$132.39 M(+4.0%) |
Dec 2004 | -$127.30 M(+28.4%) | -$127.30 M(+17.8%) |
Sep 2004 | - | -$108.06 M(+3.0%) |
Jun 2004 | - | -$104.92 M(+2.6%) |
Mar 2004 | - | -$102.21 M(+3.1%) |
Dec 2003 | -$99.15 M(+14.9%) | -$99.15 M(+3.3%) |
Sep 2003 | - | -$95.99 M(+2.1%) |
Jun 2003 | - | -$94.03 M(+5.1%) |
Mar 2003 | - | -$89.44 M(+3.6%) |
Dec 2002 | -$86.31 M(+22.6%) | -$86.31 M(+5.2%) |
Sep 2002 | - | -$82.01 M(+2.0%) |
Jun 2002 | - | -$80.39 M(+7.5%) |
Mar 2002 | - | -$74.76 M(+6.2%) |
Dec 2001 | -$70.38 M(+38.2%) | -$70.38 M(+12.3%) |
Sep 2001 | - | -$62.67 M(+6.5%) |
Jun 2001 | - | -$58.84 M(+7.6%) |
Mar 2001 | - | -$54.66 M(+7.4%) |
Dec 2000 | -$50.91 M(+28.9%) | -$50.91 M(+8.0%) |
Sep 2000 | - | -$47.16 M(+6.9%) |
Jun 2000 | - | -$44.10 M(+6.5%) |
Mar 2000 | - | -$41.41 M(+4.8%) |
Dec 1999 | -$39.49 M(+30.8%) | -$39.49 M(+6.7%) |
Sep 1999 | - | -$37.00 M(+5.4%) |
Jun 1999 | - | -$35.10 M(+6.7%) |
Mar 1999 | - | -$32.90 M(+8.9%) |
Dec 1998 | -$30.20 M(+32.5%) | -$30.20 M(+6.7%) |
Sep 1998 | - | -$28.30 M(+7.6%) |
Jun 1998 | - | -$26.30 M(+9.1%) |
Mar 1998 | - | -$24.10 M(+5.7%) |
Dec 1997 | -$22.80 M(+53.0%) | -$22.80 M(+31.0%) |
Sep 1997 | - | -$17.40 M(+4.2%) |
Jun 1997 | - | -$16.70 M(+5.7%) |
Mar 1997 | - | -$15.80 M(+6.0%) |
Dec 1996 | -$14.90 M(+46.1%) | -$14.90 M(+15.5%) |
Sep 1996 | - | -$12.90 M(+7.5%) |
Jun 1996 | - | -$12.00 M(+9.1%) |
Mar 1996 | - | -$11.00 M(+7.8%) |
Dec 1995 | -$10.20 M | -$10.20 M(+10.9%) |
Sep 1995 | - | -$9.20 M(+9.5%) |
Jun 1995 | - | -$8.40 M |
FAQ
- What is DMK Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for DMK Pharmaceuticals?
- What is DMK Pharmaceuticals annual retained earnings year-on-year change?
- What is DMK Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for DMK Pharmaceuticals?
- What is DMK Pharmaceuticals quarterly retained earnings year-on-year change?
What is DMK Pharmaceuticals annual retained earnings?
The current annual retained earnings of DMK is -$304.56 M
What is the all time high annual retained earnings for DMK Pharmaceuticals?
DMK Pharmaceuticals all-time high annual retained earnings is -$10.20 M
What is DMK Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, DMK annual retained earnings has changed by -$26.48 M (-9.52%)
What is DMK Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of DMK is -$323.47 M
What is the all time high quarterly retained earnings for DMK Pharmaceuticals?
DMK Pharmaceuticals all-time high quarterly retained earnings is -$8.40 M
What is DMK Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, DMK quarterly retained earnings has changed by -$22.23 M (-7.38%)